Review article: Pancreatic renin-angiotensin systems in health and disease

Alimentary Pharmacology and Therapeutics

Volumn 34, Issue 8, 2011, Pages 840-852

  Skipworth, J R A ^a,b   Szabadkai, G ^a   Olde Damink, S W M ^a,c   Leung, P S ^d   Humphries, S E ^a   Montgomery, H E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; CAPTOPRIL; CERULETIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; FLUOROURACIL; GEMCITABINE; METHOTREXATE; ZOFENOPRILAT;

ACUTE PANCREATITIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; DIABETES MELLITUS; DRUG INHIBITION; GLYCEMIC CONTROL; HUMAN; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CELL; PANCREAS DISEASE; PANCREAS FUNCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSINS; CARCINOMA, PANCREATIC DUCTAL; DIABETES MELLITUS; HUMANS; PANCREATIC NEOPLASMS; PANCREATITIS; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 80053187929     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04810.x     Document Type: Article

References (159)

1. Peach MJ,. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 1977; 57: 313-70. (Pubitemid 8097628)
2. Reid IA, Morris BJ, Ganong WF,. The renin-angiotensin system. Annu Rev Physiol 1978; 40: 377-410. (Pubitemid 8351313)
3. Hackenthal E, Paul M, Ganten D, Taugner R,. Morphology, physiology, and molecular biology of renin secretion. Physiol Rev 1990; 70: 1067-116. (Pubitemid 20364823)
4. Menard J,. Anthology of the renin-angiotensin system: a one hundred reference approach to angiotensin II antagonists. J Hypertens Suppl 1993; 11: S3-11. (Pubitemid 23120554)
5. Caldwell PR, Seegal BC, Hsu KC, Das M, Soffer RL,. Angiotensin-converting enzyme: vascular endothelial localization. Science 1976; 191: 1050-1.
6. Timmermans PB, Smith RD,. Angiotensin II receptor subtypes: selective antagonists and functional correlates. Eur Heart J 1994; 15 (Suppl D): 79-87.
7. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T,. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000; 52: 415-72.
8. Matsusaka T, Ichikawa I,. Biological functions of angiotensin and its receptors. Annu Rev Physiol 1997; 59: 395-412. (Pubitemid 27142448)
9. Campbell DJ, Kladis A, Duncan AM,. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 1994; 23: 439-49. (Pubitemid 24102039)
10. Brown NJ, Blais C Jr, Gandhi SK, Adam A,. ACE insertion/deletion genotype affects bradykinin metabolism. J Cardiovasc Pharmacol 1998; 32: 373-7. (Pubitemid 28399665)
11. Murphey LJ, Gainer JV, Vaughan DE, Brown NJ,. Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation 2000; 102: 829-32.
12. Margolius HS,. Kallikreins and kinins. Molecular characteristics and cellular and tissue responses. Diabetes 1996; 45 (Suppl 1): S14-9. (Pubitemid 26011983)
13. Kem DC, Brown RD,. Renin-from beginning to end. N Engl J Med 1990; 323: 1136-7.
14. Donoghue M, Hsieh F, Baronas E, et al., A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000; 87: E1-9.
15. Turner AJ, Tipnis SR, Guy JL, Rice G, Hooper NM,. ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors. Can J Physiol Pharmacol 2002; 80: 346-53. (Pubitemid 34451252)
16. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ,. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000; 275: 33238-43.
17. Vickers C, Hales P, Kaushik V, et al., Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002; 277: 14838-43. (Pubitemid 34952556)
18. Santos RA, Simoes e Silva AC, Maric C, et al., Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 2003; 100: 8258-63. (Pubitemid 36842532)
19. Toblli JE, Munoz MC, Cao G, Mella J, Pereyra L, Mastai R,. ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats. Obesity (Silver Spring) 2008; 16: 770-6. (Pubitemid 351465631)
20. Almeida AP, Frabregas BC, Madureira MM, Santos RJ, Campagnole-Santos MJ, Santos RA,. Angiotensin-(1-7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart. Braz J Med Biol Res 2000; 33: 709-13. (Pubitemid 30428611)
21. Gironacci MM, Valera MS, Yujnovsky I, Pena C,. Angiotensin-(1-7) inhibitory mechanism of norepinephrine release in hypertensive rats. Hypertension 2004; 44: 783-7. (Pubitemid 39435254)
22. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GA, Schunkert H,. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995; 92: 1387-8.
23. Reams GP,. Angiotensin-converting enzyme in renal and cerebral tissue and implications for successful blood pressure management. Am J Cardiol 1992; 69: 59C-64C.
24. Paul M, Poyan Mehr A, Kreutz R,. Physiology of local renin-angiotensin systems. Physiol Rev 2006; 86: 747-803. (Pubitemid 44033382)
25. Fowler JD, Krueth SB, Bernlohr DA, Katz SA,. Renin dynamics in adipose tissue: adipose tissue control of local renin concentrations. Am J Physiol Endocrinol Metab 2009; 296: E343-50.
26. Paizis G, Cooper ME, Schembri JM, Tikellis C, Burrell LM, Angus PW,. Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology 2002; 123: 1667-76. (Pubitemid 35231666)
27. van Kats JP, Chai W, Duncker DJ, Schalekamp MA, Danser AH,. Adrenal angiotensin: origin and site of generation. Am J Hypertens 2005; 18: 1104-10. (Pubitemid 41139910)
28. Leung PS, Sernia C,. The renin-angiotensin system and male reproduction: new functions for old hormones. J Mol Endocrinol 2003; 30: 263-70. (Pubitemid 36722617)
29. Wong TP, Debnam ES, Leung PS,. Involvement of an enterocyte renin-angiotensin system in the local control of SGLT1-dependent glucose uptake across the rat small intestinal brush border membrane. J Physiol 2007; 584 (Pt 2): 613-23. (Pubitemid 47578343)
30. Lau T, Carlsson PO, Leung PS,. Evidence for a local angiotensin- generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 2004; 47: 240-8. (Pubitemid 38315360)
31. Gembardt F, Sterner-Kock A, Imboden H, et al., Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents. Peptides 2005; 26: 1270-7. (Pubitemid 40798085)
32. Xia H, Lazartigues E,. Angiotensin-converting enzyme 2 in the brain: properties and future directions. J Neurochem 2008; 107: 1482-94.
33. Tikellis C, Bialkowski K, Pete J, et al., ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes 2008; 57: 1018-25.
34. Campbell DJ, Habener JF,. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest 1986; 78: 31-9. (Pubitemid 16068178)
35. Deschepper CF, Mellon SH, Cumin F, Baxter JD, Ganong WF,. Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal, and pituitary of the rat. Proc Natl Acad Sci U S A 1986; 83: 7552-6. (Pubitemid 16000561)
36. Dzau VJ,. Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypotheses. J Hypertens 1989; 7: 933-6. (Pubitemid 20106526)
37. Leung PS, Ip SP,. Pancreatic acinar cell: its role in acute pancreatitis. Int J Biochem Cell Biol 2006; 38: 1024-30.
38. Ganong WF,. Reproduction and the renin-angiotensin system. Neurosci Biobehav Rev 1995; 19: 241-50.
39. Leung PS, Chan WP, Wong TP, Sernia C,. Expression and localization of the renin-angiotensin system in the rat pancreas. J Endocrinol 1999; 160: 13-9. (Pubitemid 29044563)
40. Speth RC, Daubert DL, Grove KL,. Angiotensin II: a reproductive hormone too? Regul Pept 1999; 79: 25-40. (Pubitemid 29012455)
41. Chappell MC, Millsted A, Diz DI, Brosnihan KB, Ferrario CM,. Evidence for an intrinsic angiotensin system in the canine pancreas. J Hypertens 1991; 9: 751-9.
42. Leung PS, Chan HC, Fu LX, Wong PY,. Localization of angiotensin II receptor subtypes AT1 and AT2 in the pancreas of rodents. J Endocrinol 1997; 153: 269-74. (Pubitemid 27219459)
43. Ghiani BU, Masini MA,. Angiotensin II binding sites in the rat pancreas and their modulation after sodium loading and depletion. Comp Biochem Physiol A Physiol 1995; 111: 439-44.
44. Tsang SW, Cheng CH, Leung PS,. The role of the pancreatic renin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis. Regul Pept 2004; 119: 213-9. (Pubitemid 38553840)
45. Ko SH, Hong OK, Kim JW, et al., High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system. J Cell Biochem 2006; 98: 343-55.
46. Ramracheya RD, Muller DS, Wu Y, et al., Direct regulation of insulin secretion by angiotensin II in human islets of Langerhans. Diabetologia 2006; 49: 321-31. (Pubitemid 43185401)
47. Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME,. Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat. Diabetes 2004; 53: 989-97. (Pubitemid 38436611)
48. Tahmasebi M, Puddefoot JR, Inwang ER, Vinson GP,. The tissue renin-angiotensin system in human pancreas. J Endocrinol 1999; 161: 317-22. (Pubitemid 29244259)
49. Lam KY, Leung PS,. Regulation and expression of a renin-angiotensin system in human pancreas and pancreatic endocrine tumours. Eur J Endocrinol 2002; 146: 567-72. (Pubitemid 34436471)
50. Lupi R, Del Guerra S, Bugliani M, et al., The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets. Eur J Endocrinol 2006; 154: 355-61.
51. Liu WB, Wang XP, Wu K, Zhang RL,. Effects of angiotensin II receptor antagonist, Losartan on the apoptosis, proliferation and migration of the human pancreatic stellate cells. World J Gastroenterol 2005; 11: 6489-94. (Pubitemid 43136886)
52. Petersen OH, Tepikin AV,. Polarized calcium signaling in exocrine gland cells. Annu Rev Physiol 2008; 70: 273-99. (Pubitemid 351738181)
53. Hunyady L, Catt KJ,. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol 2006; 20: 953-70.
54. Chappell MC, Jacobsen DW, Tallant EA,. Characterization of angiotensin II receptor subtypes in pancreatic acinar AR42J cells. Peptides 1995; 16: 741-7.
55. Cheung WT, Yeung SY, Yiu AK, Ip TM, Wan DC, Luk SK, Ho WK,. Characterization of a functional AT1A angiotensin receptor in pancreatoma AR4-2J cells. Peptides 1999; 20: 829-36. (Pubitemid 29378284)
56. Constantinescu CS, Ventura E, Hilliard B, Rostami A,. Effects of the angiotensin converting enzyme inhibitor captopril on experimental autoimmune encaphalomyelitis. Immunopharmacol Immunotoxicol 1995; 17: 471-491.
57. Ruiz-Ortega M, Bustos C, Hernandez-Presa MA, Lorenzo O, Plaza JJ, Egido J,. ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensiuve rat model of immune complex nephritis. Kidney Int 1995; 48: 1778-1791.
58. Abbate M, Zoja C, Rottoli D, Corna D, Perico N, Bertani T, Remuzzi G,. Antiproteinuric therapy while preventing the abnormal protein raffic in proximal tubule abrogates protein-and complement-dependent interstitial inflammation in experimental renal disease. J Am Soc Nephrol 1999; 10: 804-813. (Pubitemid 29149531)
59. Molteni A, Moulder JE, Cohen EF, et al., Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enxyme inhibitiors and angiotensin II type-1 receptor blockers. IntJ Radiat Biol 2000; 76: 523-532. (Pubitemid 30232452)
60. Fukuhara M, Geary RL, Diz DI, et al., Angiotensin-converting enzyme expression in human carotid artery atherosclerosis. Hypertension 2000; 35 (1 Pt 2): 353-359. (Pubitemid 30054199)
61. Sharpe N,. The effects of ACE inhibition on progression of atherosclerosis. J Cardiovasc Pharmacol 1993; 22 (suppl 9): S9-S12. (Pubitemid 24089989)
62. Laporte S, Escher R,. Neointima formation after vascular injury is angiotensin II mediated. BiochemBiophys Res Comm 1992; 187: 1510-1516.
63. Raynolds MV, Bristow MR, Bush EW, et al., Angiotensin-converting enzyme DD genotype in patients with ischaemic or dilated cardiomyopathy. Lancet 1993; 342: 1073-1075. (Pubitemid 23338738)
64. Krootila K, Oksala O, Von Dickhoff K, Palkama A, Uusitalo H,. Effect of captopril on ocular irratative response to topical neutral formaldehyde and YAG-lasar capsulotomy in the rabbit. J Ocul Pharmacol Ther 1995; 11: 243-252.
65. Nagai N, Izumi-Nagai K, Oike Y, et al., Suppression of Diabetes-Induced Retinal Inflammation by Blocking the Angiotensin II Type 1 Receptor or Its Downstream Nuclear Factor-{kappa}B Pathway. Invest Ophthalmol Vis Sci 2007; 48: 4342-50. (Pubitemid 351261068)
66. Wolf G, Wenzel U, Burns KD, Harris RC, Stahl RA, Thaiss F,. Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors. Kidney Int 2002; 61: 1986-95. (Pubitemid 34539316)
67. Skurk T, van Harmelen V, Hauner H,. Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-kappaB. Arterioscler Thromb Vasc Biol 2004; 24: 1199-203. (Pubitemid 38880008)
68. Peeters AC, Netea MG, Kullberg BJ, Thien T, van der Meer JW,. The effect of renin-angiotensin system inhibitors on pro-and anti-inflammatory cytokine production. Immunology 1998; 94: 376-9. (Pubitemid 28318603)
69. Gullestad L, Aukrust P, Ueland T, et al., Effect of high-versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. J Am Coll Cardiol 1999; 34: 2061-7. (Pubitemid 30002665)
70. Chipitsyna G, Gong Q, Gray CF, Haroon Y, Kamer E, Arafat HA,. Induction of monocyte chemoattractant protein-1 expression by angiotensin II in the pancreatic islets and beta-cells. Endocrinology 2007; 148: 2198-208. (Pubitemid 46997051)
71. Yamada T, Kuno A, Masuda K, et al., Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats. J Pharmacol Exp Ther 2003; 307: 17-23. (Pubitemid 37151887)
72. Chan YC, Leung PS,. Acute pancreatitis: animal models and recent advances in basic research. Pancreas 2007; 34: 1-14. (Pubitemid 46045717)
73. Wedgewood K, Reber HA,. Acute pancreatitis: the concepts of pathogenesis. In:, Howard J, Jordan G, Reber HA, eds. Surgical diseases of the pancreas. Philadelphia, PA: Lea & Febiger, 1986: 12-25.
74. Bouffard L, Papirakis ME, Maheux P,. Enalapril increases the local extravasation of macromolecules and nitric oxide synthase in pancreas of the fructose-fed insulin-resistant rat model. Pancreas 2006; 33: 418-24. (Pubitemid 44690734)
75. Kanbay M, Selcuk H, Yilmaz U, Boyacioglu S,. Recurrent acute pancreatitis probably secondary to lisinopril. South Med J 2006; 99: 1388-9. (Pubitemid 46035559)
76. Famularo G, Minisola G, Nicotra GC, De Simone C,. Idiosyncratic pancreatitis associated with perindopril. JOP 2005; 6: 605-7. (Pubitemid 41671981)
77. Singh S,. Angiotensin-converting enzyme (ACE) inhibitor-induced acute pancreatitis: in search of the evidence. South Med J 2006; 99: 1327-8. (Pubitemid 46035548)
78. Eland IA, Sundstrom A, Velo GP, et al., Antihypertensive medication and the risk of acute pancreatitis: the European case-control study on drug-induced acute pancreatitis (EDIP). Scand J Gastroenterol 2006; 41: 1484-90. (Pubitemid 44764411)
79. Knoefel WT, Kollias N, Warshaw AL, Waldner H, Nishioka NS, Rattner DW,. Pancreatic microcirculatory changes in experimental pancreatitis of graded severity in the rat. Surgery 1994; 116: 904-13. (Pubitemid 24347201)
80. Foitzik T, Fernandez-del Castillo C, Rattner DW, Klar E, Warshaw AL,. Alcohol selectively impairs oxygenation of the pancreas. Arch Surg 1995; 130: 357-60.
81. Kuwahira I, Gonzalez NC, Heisler N, Piiper J,. Changes in regional blood flow distribution and oxygen supply during hypoxia in conscious rats. J Appl Physiol 1993; 74: 211-4. (Pubitemid 23059747)
82. Morrell NW, Atochina EN, Morris KG, Danilov SM, Stenmark KR,. Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. J Clin Invest 1995; 96: 1823-33.
83. Neylon M, Marshall J, Johns EJ,. The role of the renin-angiotensin system in the renal response to moderate hypoxia in the rat. J Physiol 1996; 491 (Pt 2): 479-88. (Pubitemid 26081737)
84. Leung PS, Lam SY, Fung ML,. Chronic hypoxia upregulates the expression and function of AT(1) receptor in rat carotid body. J Endocrinol 2000; 167: 517-24. (Pubitemid 32047559)
85. Leung PS, Wong TP, Sernia C,. Angiotensinogen expression by rat epididymis: evidence for an intrinsic, angiotensin-generating system. Mol Cell Endocrinol 1999; 155: 115-22. (Pubitemid 29460970)
86. Morrell NW, Danilov SM, Satyan KB, Morris KG, Stenmark KR,. Right ventricular angiotensin converting enzyme activity and expression is increased during hypoxic pulmonary hypertension. Cardiovasc Res 1997; 34: 393-403. (Pubitemid 27241585)
87. Chan WP, Fung ML, Nobiling R, Leung PS,. Activation of local renin-angiotensin system by chronic hypoxia in rat pancreas. Mol Cell Endocrinol 2000; 160: 107-14. (Pubitemid 30129057)
88. Greenstein RJ, Krakoff LR, Felton K,. Activation of the renin system in acute pancreatitis. Am J Med 1987; 82: 401-4.
89. Pitchumoni CS, Agarwal N, Jain NK,. Systemic complications of acute pancreatitis. Am J Gastroenterol 1988; 83: 597-606.
90. Ibis M, Yuksel O, Yilmaz G, et al., Serum angiotensin converting enzyme levels in pancreatic diseases. Hepatogastroenterology 2008; 55: 1814-7.
91. Leung PS, Chan WP, Nobiling R,. Regulated expression of pancreatic renin-angiotensin system in experimental pancreatitis. Mol Cell Endocrinol 2000; 166: 121-8.
92. Tsang SW, Ip SP, Leung PS,. Prophylactic and therapeutic treatments with AT 1 and AT 2 receptor antagonists and their effects on changes in the severity of pancreatitis. Int J Biochem Cell Biol 2004; 36: 330-9. (Pubitemid 37487767)
93. Wang XP, Zhang R, Wu K, Wu L, Dong Y,. Angiotensin II mediates acinar cell apoptosis during the development of rat pancreatic fibrosis by AT1R. Pancreas 2004; 29: 264-70. (Pubitemid 40228271)
94. Chan YC, Leung PS,. AT1 Receptor-Dependent NF{kappa}B Activation-Mediated Pro-Inflammatory Actions in a Rat Model of Obstructive Acute Pancreatitis. J Pharmacol Exp Ther 2007; 323: 10-8.
95. Grobe JL, Der Sarkissian S, Stewart JM, Meszaros JG, Raizada MK, Katovich MJ,. ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts. Clin Sci (Lond) 2007; 113: 357-64. (Pubitemid 47572276)
96. Zhong JC, Yu XY, Lin QX, Li XH, Huang XZ, Xiao DZ, Lin SG,. Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression. Br J Pharmacol 2008; 153: 66-74.
97. Kuno A, Yamada T, Masuda K, et al., Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats. Gastroenterology 2003; 124: 1010-9. (Pubitemid 36389804)
98. Chen P, Yuan Y, Wang S, Zhan L, Xu J,. Captopril, an Angiotensin- converting enzyme inhibitor, attenuates the severity of acute pancreatitis in rats by reducing expression of matrix metalloproteinase 9. Tohoku J Exp Med 2006; 209: 99-107.
99. Tsang SW, Ip SP, Wong TP, Che CT, Leung PS,. Differential effects of saralasin and ramiprilat, the inhibitors of renin-angiotensin system, on cerulein-induced acute pancreatitis. Regul Pept 2003; 111: 47-53. (Pubitemid 36254748)
100. Chan YC, Leung PS,. AT1 receptor antagonism ameliorates acute pancreatitis-associated pulmonary injury. Regul Pept 2006; 134: 46-53.
101. Duchen MR, Szabadkai G,. Roles of mitochondria in human disease. Essays Biochem 2010; 47: 115-37.
102. Petersen OH, Gerasimenko OV, Tepikin AV, Gerasimenko JV,. Aberrant Ca(2+) signalling through acidic calcium stores in pancreatic acinar cells. Cell Calcium 2011 [Epub ahead of print].
103. Gerasimenko JV, Lur G, Ferdek P, et al., Calmodulin protects against alcohol-induced pancreatic trypsinogen activation elicited via Ca2+ release through IP3 receptors. Proc Natl Acad Sci U S A 2011; 108: 5873-8.
104. Petersen OH, Sutton R,. Ca2+ signalling and pancreatitis: effects of alcohol, bile and coffee. Trends Pharmacol Sci 2006; 27: 113-20. (Pubitemid 43184033)
105. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F,. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-6. (Pubitemid 20370444)
106. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GA, Schunkert H,. Angiotensin converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995; 92: 1387-1388.
107. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F,. Angiotensin-I converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993; 290: 33-40. (Pubitemid 23081197)
108. Oruc N, Papachristou GI, Avula H, Slivka A, Lamb J, Whitcomb DC,. Angiotensin-converting enzyme gene DD genotype neither increases susceptibility to acute pancreatitis nor influences disease severity. HPB (Oxford) 2009; 11: 45-9.
109. Hucl T, Kylanpaa ML, Kunzli B, et al., Angiotensin-converting enzyme insertion/deletion polymorphism in patients with acute and chronic pancreatitis. Eur J Gastroenterol Hepatol 2009; 21: 1032-5.
110. Oruc N, Lamb J, Kutlu OC, Barmada MM, Money ME, Slivka A, Whitcomb DC,. The functional angiotensin converting enzyme gene I/D polymorphism does not alter susceptibility to chronic pancreatitis. Jop 2004; 5: 457-63. (Pubitemid 41573848)
111. Hucl T, Kylanpaa ML, Kunzli B, et al., Angiotensin-converting enzyme insertion/deletion polymorphism in patients with acute and chronic pancreatitis. Eur J Gastroenterol Hepatol 2009; 21: 1032-5.
112. Bhaskar S, Reddy DN, Mahurkar S, Rao GV, Singh L, Chandak GR,. Lack of significant association of an insertion/deletion polymorphism in the angiotensin converting enzyme (ACE) gene with tropical calcific pancreatitis. BMC Gastroenterol 2006; 6: 42.
113. Norris B, Gonzalez C, Concha J, Palacios S, Contreras G,. Stimulatory effect of angiotensin II on electrolyte transport in canine tracheal epithelium. Gen Pharmacol 1991; 22: 527-31.
114. Cox HM, Cuthbert AW, Munday KA,. The effect of angiotensin II upon electrogenic ion transport in rat intestinal epithelia. Br J Pharmacol 1987; 90: 393-401. (Pubitemid 17232870)
115. Fink AS, Wang Y, Mendez T, Worrell RT, Eaton D, Nguyen TD, Lee SP,. Angiotensin II evokes calcium-mediated signaling events in isolated dog pancreatic epithelial cells. Pancreas 2002; 25: 290-5.
116. Howard-McNatt M, Fink AS,. Captopril inhibits secretin-induced pancreatic bicarbonate output. J Surg Res 2002; 103: 96-9. (Pubitemid 34953397)
117. Chan HC, Law SH, Leung PS, Fu LX, Wong PY,. Angiotensin II receptor type I-regulated anion secretion in cystic fibrosis pancreatic duct cells. J Membr Biol 1997; 156: 241-9. (Pubitemid 27208426)
118. Cheng HS, So SC, Law SH, Chan HC,. Angiotensin II-mediated signal transduction events in cystic fibrosis pancreatic duct cells. Biochim Biophys Acta 1999; 1449: 254-60. (Pubitemid 29164382)
119. Cheng HS, Wong WS, Chan KT, Wang XF, Wang ZD, Chan C,. Modulation of Ca2+-dependent anion secretion by protein kinase C in normal and cystic fibrosis pancreatic duct cells. Biochim Biophys Acta 1999; 1418: 31-8. (Pubitemid 29182744)
120. Amaya K, Ohta T, Kitagawa H, et al., Angiotensin II activates MAP kinase and NF-kappaB through angiotensin II type I receptor in human pancreatic cancer cells. Int J Oncol 2004; 25: 849-56.
121. Jiang H, Li ZS, Xu GM, Tu ZX, Gong YF,. Angiotensin II type 1 receptor mRNA and its protein expression in human pancreatic cancer cell lines. Chin J Dig Dis 2004; 5: 68-71. (Pubitemid 38594317)
122. Ohta T, Yi S, Amaya K, et al., Intrinsic angiotensin II-generating system in human pancreatic cancer tissues. Gan To Kagaku Ryoho 2002; 29: 2325-8.
123. Ohta T, Amaya K, Yi S, et al., Angiotensin converting enzyme-independent, local angiotensin II-generation in human pancreatic ductal cancer tissues. Int J Oncol 2003; 23: 593-8.
124. Fujimoto Y, Sasaki T, Tsuchida A, Chayama K,. Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. FEBS Lett 2001; 495: 197-200. (Pubitemid 32397704)
125. Zhou L, Zhang R, Yao W, et al., Decreased expression of angiotensin-converting enzyme 2 in pancreatic ductal adenocarcinoma is associated with tumor progression. Tohoku J Exp Med 2009; 217: 123-31.
126. Anandanadesan R, Gong Q, Chipitsyna G, Witkiewicz A, Yeo CJ, Arafat HA,. Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling. J Gastrointest Surg 2008; 12: 57-66.
127. Arafat HA, Gong Q, Chipitsyna G, Rizvi A, Saa CT, Yeo CJ,. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma. J Am Coll Surg 2007; 204: 996-1005. (Pubitemid 46661215)
128. Molteni A, Ward WF, Ts'ao CH, Taylor J, Small W Jr, Brizio-Molteni L, Veno PA,. Cytostatic properties of some angiotensin I converting enzyme inhibitors and of angiotensin II type I receptor antagonists. Curr Pharm Des 2003; 9: 751-61. (Pubitemid 36367596)
129. Reddy MK, Baskaran K, Molteni A,. Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells. Proc Soc Exp Biol Med 1995; 210: 221-6. (Pubitemid 26020247)
130. Ishikawa T, Kamimura H, Tsuchiya A, et al., Clinical efficacy of intra-arterial pharmacokinetic chemotherapy with 5-fluorouracil, CDDP, gemcitabine, and angiotensin-II in patients with advanced pancreatic cancer. Hepatogastroenterology 2007; 54: 2378-82.
131. Ohigashi H, Ishikawa O, Yokayama S, et al., Intra-arterial infusion chemotherapy with angiotensin-II for locally advanced and nonresectable pancreatic adenocarcinoma: further evaluation and prognostic implications. Ann Surg Oncol 2003; 10: 927-34. (Pubitemid 40486859)
132. Omary MB, Lugea A, Lowe AW, Pandol SJ,. The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest 2007; 117: 50-9. (Pubitemid 46048449)
133. Hama K, Ohnishi H, Aoki H, et al., Angiotensin II promotes the proliferation of activated pancreatic stellate cells by Smad7 induction through a protein kinase C pathway. Biochem Biophys Res Commun 2006; 340: 742-50. (Pubitemid 43053893)
134. Carlsson PO, Berne C, Jansson L,. Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia 1998; 41: 127-33. (Pubitemid 28088387)
135. Huang Z, Jansson L, Sjoholm A,. Vasoactive drugs enhance pancreatic islet blood flow, augment insulin secretion and improve glucose tolerance in female rats. Clin Sci (Lond) 2007; 112: 69-76. (Pubitemid 46120087)
136. Huang Z, Jansson L, Sjoholm A,. Pancreatic islet blood flow is selectively enhanced by captopril, irbesartan and pravastatin, and suppressed by palmitate. Biochem Biophys Res Commun 2006; 346: 26-32. (Pubitemid 43865964)
137. Wong PF, Lee SS, Cheung WT,. Immunohistochemical colocalization of type II angiotensin receptors with somatostatin in rat pancreas. Regul Pept 2004; 117: 195-205. (Pubitemid 38121655)
138. Fliser D, Schaefer F, Schmid D, Veldhuis JD, Ritz E,. Angiotensin II affects basal, pulsatile, and glucose-stimulated insulin secretion in humans. Hypertension 1997; 30: 1156-61. (Pubitemid 27476173)
139. Abuissa H, Jones PG, Marso SP, O'Keefe JH Jr,. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 2005; 46: 821-6. (Pubitemid 41224805)
140. Otterstad JE, Sleight P,. The HOPE study: comparison with other trials of secondary prevention. Eur Heart J 2001; 22: 1307-10. (Pubitemid 32737622)
141. Jandeleit-Dahm KA, Tikellis C, Reid CM, Johnston CI, Cooper ME,. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. J Hypertens 2005; 23: 463-73. (Pubitemid 40684700)
142. Gillespie EL, White CM, Kardas M, Lindberg M, Coleman CI,. The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes. Diabetes Care 2005; 28: 2261-6. (Pubitemid 41242483)
143. Andraws R, Brown DL,. Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials). Am J Cardiol 2007; 99: 1006-12. (Pubitemid 46483294)
144. Scheen AJ,. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials. Diabetes Metab 2004; 30: 487-96. (Pubitemid 40070350)
145. Scheen AJ,. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms. Diabetes Metab 2004; 30: 498-505. (Pubitemid 40073639)
146. Scheen AJ,. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system. Drugs 2004; 64: 2537-65. (Pubitemid 39591650)
147. Mason JM, Dickinson HO, Nicolson DJ, Campbell F, Ford GA, Williams B,. The diabetogenic potential of thiazide-type diuretic and beta-blocker combinations in patients with hypertension. J Hypertens 2005; 23: 1777-81. (Pubitemid 41830411)
148. Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL,. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med 2000; 342: 905-12. (Pubitemid 30177050)
149. Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenbuttel BH, Zinman B,. Ramipril and the development of diabetes. Jama 2001; 286: 1882-5. (Pubitemid 33010241)
150. Chu KY, Lau T, Carlsson PO, Leung PS,. Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes 2006; 55: 367-74. (Pubitemid 43343265)
151. Shao J, Iwashita N, Ikeda F, et al., Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db/db mice. Biochem Biophys Res Commun 2006; 344: 1224-33.
152. Nakayama M, Inoguchi T, Sonta T, et al., Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonist. Biochem Biophys Res Commun 2005; 332: 927-33. (Pubitemid 40798176)
153. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW,. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-8. (Pubitemid 24176909)
154. Pollare T, Lithell H, Berne C,. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989; 321: 868-73. (Pubitemid 19238619)
155. Santoro D, Natali A, Palombo C, Brandi LS, Piatti M, Ghione S, Ferrannini E,. Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension. Hypertension 1992; 20: 181-91.
156. Haenni A, Andersson PE, Lind L, Berne C, Lithell H,. Electrolyte changes and metabolic effects of lisinopril/bendrofluazide treatment. Results from a randomized, double-blind study with parallel groups. Am J Hypertens 1994; 7 (7 Pt 1): 615-22. (Pubitemid 24265157)
157. Santos SH, Fernandes LR, Mario EG, et al., Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism. Diabetes 2008; 57: 340-7.
158. Herath CB, Warner FJ, Lubel JS, et al., Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. J Hepatol 2007; 47: 387-95. (Pubitemid 47176156)
159. Paizis G, Tikellis C, Cooper ME, et al., Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 2005; 54: 1790-6. (Pubitemid 41697680)